Filtering by:
Cancer UpdatesWomen Face Gaps in Use of Genetic Counseling to Make Breast Cancer Treatment Decisions
Genetic testing is an important tool in making breast cancer treatment decisions, and it's more widely available today than ever before. But many women are still not getting all the information they need.
Leading Cancer Groups Chart the Future of Disparities Research
Four leading national cancer organizations have released a joint statement outlining a strategy to help all cancer patients benefit from cancer research, regardless of race, ethnicity, age, gender, sexual orientation, socioeconomic status, or where they live.
FDA Approves Nerlynx (Neratinib) for a type of Breast Cancer
The US Food and Drug Administration (FDA) has approved the first extended adjuvant therapy for early-stage, HER2-postive breast cancer.
Panel Backs CAR T-cell Therapy for Leukemia: What You Need to Know and What’s Next
The US and Drug Administration (FDA) this week convened a panel of outside experts to weigh in on the readiness of a first-of-its-kind cancer treatment called CAR T-cell therapy. The panel unanimously recommended that the agency approve the treatment. What does this mean for patients? And is CAR T-cell therapy going to play an increasing role in cancer treatment in general? In this interview, Leonard Lichtenfeld, MD, MACP, American Cancer Society deputy chief medical officer, gives us his take.